ATM mutations in Finnish breast cancer patients [3]

Journal of Medical Genetics

Volumn 39, Issue 3, 2002, Pages 192-196

  Allinen, M ^a   Launonen, V ^a   Laake, K ^a   Jansen, L ^a   Huusko, P ^a   Kaariainen H ^a   Borresen Dale A L ^a   Winqvist, Robert ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; GENE PRODUCT;

ADULT; BREAST CARCINOMA; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC SCREENING; GENETIC STABILITY; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; EXONS; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; MALE; PEDIGREE; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS; VARIATION (GENETICS);

EID: 0036193825     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (27)

1. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
2. Identification of the breast cancer susceptibility gene BRCA2
3. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: Evidence for additional susceptibility genes
4. A low proportion of BRCA2 mutations in Finnish breast cancer families
5. Evidence of founder mutations in Finnish BRCA1 and BRCA2 families
6. Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus
7. Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites
8. Breast and other cancers in families with ataxia-telangiectasia
9. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: Expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer
10. Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries
11. A single ataxia telangiectasia gene with a product similar to Pl-3 kinase
12. Eighth international workshop on ataxia-telangiectasia (ATW8)
13. Characterization of ATM mutations in 41 Nordic families with ataxia telangiectasia
14. Molecular genetics of the Finnish disease heritage
15. Predominance of null mutations in ataxia-telangiectasia
16. ATM mutations in patients with ataxia telangiectasia screened by a hierarchical strategy
17. Mutations of the ATM gene detected in Japanese ataxia-telangiectasia patients: Possible preponderance of the two founder mutations 4612del165 and 7883del5
18. Identical mutation in 55% of the ATM alleles in 11 Norwegian AT families: Evidence for a founder effect
19. Ataxia-telangiectasia: Identification and detection of founder-effect mutations in the ATM gene in ethnic populations
20. Heterozygosity for mutations in the ataxia-telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients
21. The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species
22. ATM mutations in cancer families
23. Rapid and efficient ATM mutation detention by fluorescent chemical cleavage of mismatch: Identification of four novel mutations
24. Cancer risk in ATM heterozygotes: A model of phenotypic and mechanistic differences between missense and truncation mutations
25. Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene
26. The DNA damage response: Putting checkpoints in perspective
27. ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses